Skip to content

APO CASDAN

Active
Private limited companyfounded 201214 yrs activeAcaciadreef 21, 2900 Schoten, BelgiumKBO/BCE: BE 0847.478.904
Summary

APO CASDAN has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€62,160) and a net result of -€27,733. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 10% of 11293 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.0% (low).

Overview

What they do
Retail sale of pharmaceutical products
NACE 47730
1 site
How big
€436,566total assets 2025
Staff
5.7 FTE
Equity
-€62,160
Loss
-€27,733
Turnover not published (abridged schema)
Financially healthy?
28 Weak Checked score 2025
Bankruptcy chance 12 m
1.0%
Who decides
Parent
Beheer- en managementmaatschappij La Garenne · 99%
Board
1 member
Accounts 50 d early1 of 6 deeds read
Why 28- Higher-failure-rate sector- Annual accounts: weaker financial profile- Negative equity+ Long track recordLatest accounts filed on timeShow the evidence

Checked score

Score 2025
Axes · tick = 2024
Profitability11▼-18
Solvency11▼-5
Growth32=
Track record100
Bankruptcy probability, 12 months
1.0% Low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.84 against 0.9 in 2024; short-term debt: 114.2% and cash: 2.7% of total assets), and equity is negative.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
-14.2%
Return on assets
-6.4%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 14 years 0 20 y
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year -€62,160
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 11-06-2026, 50 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
50 d early
2024
31 d early
2023
28 d early
2022
32 d early
2021
31 d early
2020
25 d early
2019
30 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 32 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 30 June (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
02-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · abbreviated…
  2. Resignation: BM Garenne nv (director)Permanent representative: Melissa Van Waeyenberge…
  3. Annual accounts filedfiscal year 2024 · abbreviated…

Key points

  • Risk: Negative equityfiscal year 2025: debts exceed assets -€62,160 View
  • Caution: Among the weakest 8% on equitysector median €247,818 · 11,303 companies -€62,160 View
  • Caution: Board changedlatest change 01-01-2026 · 1 in office 1 joined · 1 left View
  • Positive: Always filed on timeaccounts within the deadline every year 8 years View
  • Controlled by Beheer- en managementmaatschappij La… 99% View

By topic

Financials

Fiscal year
2025
Total assets
€436,566
Loss
-€27,733
Solvency
-14.2%
Total assets▲ 10.0%
Net result
20182025
Go to Financials

Timeline

Events
14
Since
2017
Next accounts
by 31-07-2027
  1. 11-06-2026Annual accounts filed
  2. 05-05-2026Resignation: BM Garenne nv (director)
  3. 30-06-2025Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
16-07-2012
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.